Clinical trials in Montpellier – page 69

Innovative clinical trials focusing on head and neck cancer, bladder cancer, and mantle cell lymphoma. Studies evaluate combination therapies and novel treatment approaches for improved patient outcomes.

• Advanced HNSCC Treatment Combinations
• Non-muscle Invasive Bladder Cancer Therapy
• Gastric Cancer Targeted Treatments

Research includes evaluation of immunotherapy combinations and targeted molecular approaches.

Studies examining innovative treatments for Crohn's disease, multiple sclerosis, and systemic sclerosis. Research focuses on novel therapeutic approaches and treatment optimization.

• Fecal Microbiota Transplantation Studies
• MS Treatment De-escalation Strategies
• Advanced Autoimmune Therapies

Trials aim to improve disease management and patient quality of life.

Investigating treatments for achondroplasia, pyruvate dehydrogenase deficiency, and thyroid eye disease. Focus on developing targeted therapies for these uncommon conditions.

• Growth Disorders in Children
• Metabolic Disease Management
• Innovative Therapeutic Approaches

Research aims to address unmet medical needs in rare disease populations.

Clinical trials evaluating vaccines for cytomegalovirus, yellow fever, and HPV prevention. Studies focus on immunization effectiveness and safety profiles.

• Vaccine Development Programs
• Infection Prevention Strategies
• Population Health Protection

Research emphasizes disease prevention and public health improvement.